ORPEA Société Anonyme Reports Consolidated Revenue Results for the Fourth Quarter and Full Year Ended 31 December 2016; Provides Revenue Guidance for 2017
For the quarter, total revenue was 736.6 million against 649.0 million a year ago.
In 2017, the company now confidently forecasts revenue of 3,125 million. This represents a healthy increase of 10% (or 283 million) from consistently brisk organic growth and from acquisitions, including Sanyres in Spain over a full 12 months and Spitex Ville et Campagne in Switzerland over a full 12 months.